Suzuken Co., Ltd. announces an Equity Buyback for 5,500,000 shares, representing 6.25% for ¥20,000 million.
November 11, 2022 at 06:00 am
Share
Suzuken Co., Ltd. (TSE:9987) announces a share repurchase program. Under the program, the company will repurchase 5,500,000 shares, representing 6.25% of its share capital, for ¥20,000 million. The company will repurchase its shares in order to carry out agile capital policies in response to changes in the business environment.
The program will run until March 10, 2023. As of October 31, 2022, the company had 88,000,000 shares issued (excluding treasury shares) and 26,210 shares in treasury.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
